SF Opioid Crisis Not From Allergan's Market Share, Judge Told
By Bonnie Eslinger · June 15, 2022, 11:05 PM EDT
An economics expert for Allergan testified Wednesday in a bellwether opioid bench trial that the "extremely small" market share and promotion done for the company's two branded opioids could not have...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login